Background: Food allergy is major public health concern affecting nearly 15 million Americans and 80 million Europeans. Risk of anaphylaxis and implications for social activities affect patients' quality of life and psychological well-being. We previously found that young patients reported higher levels of alexithymia (difficulty in recognizing and expressing emotions) compared with healthy peers and may influence affect, management style and clinical outcomes. This study aimed to explore links between coping strategies, alexithymia and anxiety among food-allergic adolescents and young adults. Methods: Ninety-two patients with IgE-mediated food allergy (mean age 18.6 years) completed Coping Orientation to Problems Experienced Inventory, Toronto Alexithymia Scale and Trait Anxiety subscale of State-Trait Anxiety Inventory. Multivariate analyses of variance assessed differences and associations between subgroups on the scales. Results: Significant differences found between alexithymia levels in coping style were explained by Avoidance strategies. 'Avoidance' had the highest contribution in explaining alexithymia, followed by trait anxiety, age, anaphylaxis and social support. Respondents with higher alexithymia use avoidance as coping strategy over and above other coping strategies such as problem-solving and positive thinking, are younger, will have experienced anaphylaxis and will have lower social support. Conclusions: Recognizing the specific role of affect regulation in health behaviours may constitute an important step in supporting patients to explore more adaptive strategies.
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Food allergy is major public health concern affecting nearly 15 million Americans and 80 million Europeans, including 8% of children, with high costs to public health services (1) (2) (3) (4) . Reactions can occur on initial exposure, from minimal quantities, and range from mild to life-threatening. Avoidance of the trigger food(s) is central to management, but accidental ingestion is common. The likelihood of a fatal reaction is low with an annual incidence of 1.8 in adults and 3.25 in food-allergic children and adolescents per million person-years (3) . Therefore, although preventing fatalities should always be a central concern, health-related quality of life (HRQL) and other patient-related measures may be more meaningful measures of outcome in food allergy research and practice. The real fear factor of life-threatening reactions, together with the need for constant vigilance and the implications for daily routines and social activities, affects patients' quality of life and psychological well-being. In recent years, an increasing number of HRQL studies provide insight into the everyday food allergy experience and which issues need to be addressed during consultations (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . However, little is known about psychological characteristics and how they might impact outcomes among these patients. This is an important area of study as research has shown that foodallergic adolescents have significantly higher internalizing problems such as anxiety, depression, relational difficulties, and higher impact of psychological problems on everyday life, than healthy peers (14, 15) . With regard to personality characteristics, we previously found that young people with food allergy reported higher levels of alexithymia compared with a matched healthy sample. Alexithymia was found to be associated with previous anaphylaxis among patients (13) .
Alexithymia is a multifaceted personality construct described as 'a lack of words to express emotions' (16) . Alexithymia is described on a continuum and normally distributed in the general population, where prevalence is 10-13% (17) (18) (19) . Interest in alexithymia has increased considerably particularly within interdisciplinary research with numerous investigations in clinical research, cognitive psychology, neurobiology and psycho-neuro-endocrinology (17) . From the first introduction of the term, the construct of alexithymia has been evaluated, criticized and subsequently modified. The construct describes a difficulty in identifying feelings (DIF) and distinguishing between feelings and the bodily sensations of emotional arousal; constricted imagination, difficulty describing feelings to other people; and a stimulus-bound, externally oriented cognitive style (20) . In effect, an individual will misread the physical expression of emotion as a physical expression of disease and vice versa, for example by interpreting an anxious tightening in the stomach as food poisoning. 'Constricted imagination' gives rise to difficulties in regulating type and intensity of emotional expression, while an 'external-oriented cognitive style' describes a propensity to be guided by strict rules, regulations and social conformity, which provide a sense of comfort and security, rather than by emotions, which give rise to uncertainty and distress.
The validity of the alexithymia construct and its association with several common psychiatric and medical illnesses are well documented (21) (22) (23) . Alexithymia plays a role in influencing clinical outcomes (17, 18) and is associated with a lack of constructive coping strategies such as the ability to modulate emotional arousal, to properly express or suppress emotions, to gain and use social support (SS) or to cope with painful emotions (21, 23) , resulting in avoidant coping and negative affect. Avoidant coping strategies are associated with psychological distress in food allergy and can mediate the link between illness perceptions and outcome. Focusing on and venting of emotions significantly predicted greater stress, somatic symptoms, anxiety and insomnia and severe depression (24) .
This study aimed to explore links between coping strategies, alexithymia and anxiety among food-allergic adolescents and young adults, using validated and widely used instruments. Additionally, the influence of food allergy-related variables such as previous anaphylaxis and adrenaline prescription was investigated. An increased understanding of the interplay between the role of alexithymia in influencing clinical outcomes through a relationship with coping style and negative affect can help to provide practical suggestions for prevention and intervention in food allergy in research and in practice.
Methods

Procedure
The sample of food-allergic patients was recruited sequentially during clinical visits at the Food Allergy Centre of Veneto Region, in Padua, considering the inclusion and exclusion criteria. Inclusion criteria consisted of being confirmed suffering from IgE-mediated food allergy by an allergist on the basis of a clinical history with positive skin prick test, in vitro specific IgE and a positive food challenge. Patients were excluded when they suffered from serious concomitant nonallergic disease, including psychological disorders (e.g. in our sample no participant showed symptoms of autism spectrum disorder). Clinical information was collected through a cross -check between parents/patients' report and hospital records.
Two patients refused to take part in the study. Individuals who agreed to complete the questionnaires gave their oral consent or signed directly if 18 years old or older. Parents signed informed consent for the younger participants.
The study was approved by the Ethic Committee of Psychological Research of Padua University.
Instruments
COPE-NIV
The Coping Orientation to Problems Experienced-New Italian Version (COPE-NIV) Inventory was used to assess a broad range of coping responses. It consists of 60 items reflecting different adaptive and maladaptive coping strategies. We used the 'dispositional' or trait-like version in which respondents' report the extent to which they usually do the things listed, when they are stressed. The COPE-NIV is a valid tool for measuring coping styles in the Italian context. Factor analysis showed five large essentially independent dimensions: Social Support (SS), Avoidance strategies (AS), Positive attitude (PA), Problem-solving (PS) and Turning to religion (TR). These five dimensions are substantially independent of each other, reliable and fairly stable in time; no essential difference was identified in relation to the level of education, gender and age. Avoidance strategies were found to be the conditions largely associated with emotional distress, whereas PA and PS were related to less distress and greater psychological well-being.
TAS-20
The Toronto Alexithymia Scale, TAS-20 (25) , Italian version (26) , was used to assess alexithymia in participants. This validated and widely used self-rating questionnaire measures three different core factors in alexithymia: F1, difficulty identifying feelings and distinguishing between feelings and the bodily sensations of emotional arousal (DIF); F2, difficulty in describing feelings (DDF); and F3, externally oriented thinking (EOT); it is also for categorization of respondents into three groups: nonalexithymic (score <51), borderline (score between 51 and 60) and alexithymic (score = >61).
The original English Scale, as well as its Italian version, showed adequate validity and reliability among adults and teenagers (25, 27, 28) . 
Statistical analysis
Preliminary checks were carried out to ensure data met the requirements for the statistical tests selected in terms of linearity and normality (31, 32) . Following a descriptive profile, a series of multivariate analyses of variance were conducted to assess for differences and associations between subgroups (level of alexithymia, type of coping strategy, trait anxiety, anaphylaxis, age group, gender) and to control for the effects of all independent variables on dependent variables simultaneously. Dependent variables included COPE subscales and STAI total score (Trait). Independent categorical variables included age and gender, alexithymia categories and subscales, adrenaline prescription, and previous anaphylaxis experience.
An effect size index in ANOVA is denoted by eta-squared (g 2 ). Effect size is a simple way of quantifying the difference between subgroups that provides an advantage over the use of tests of statistical significance alone (31, 32) . Effect sizes for g 2 are as follows: 0.01 (a small effect), 0.06 (a moderate effect), 0.14+ (a large effect).
Results
Participants
A total of 92 participants aged 14-32 (mean age = 18.6, SD = 5.2; 50% female) were involved. Main characteristics of the sample are shown in Table 1 . Half of participants reported experiencing anaphylaxis, and the majority (N = 82) had been prescribed self-injectable adrenaline on the basis of current guidelines (4). Patients came from Veneto Region (north-eastern Italy) and developed food allergy in early childhood. Forty-nine were below the cut-off point on the summative scale for alexithymia (<51.0); 29 individuals were borderline (51.0-60.0), with the remainder (N = 14) above the cut-off for alexithymia (>61.0). Mean scores for each scale (response range 1-5) were mean = 2.5, SD = 0.9 for DDF; mean = 2.3, SD = 0.8 for DIF; mean = 2.6, SD = 0.5 for EOT (Table 2) . Post hoc power analysis revealed a power of 0.9 to detect differences at a 95% confidence interval for a multivariate analysis of the relationship between all dependent and independent variables. Table 2 shows alexithymia total score and subscales scores according to participant category. The total score increases from 41.0 for those below the borderline to 67.4 for those above. The highest mean scores were reported for DIF subscale (mean = 25.0, SD = 4.8), followed by EOT (mean = 23.3, SD = 4.0), and DDF (M = 19.2, SD = 3.0). Table 2 also shows the mean score for trait anxiety (mean = 49.1, SD = 10.6) for those above the borderline, compared with mean = 38.0, SD = 9.5, for those below the borderline. There is a decrease in the mean score in SS, PA and PS subscales and an increase in scores for AS and TR subscales for those below versus those above the borderline for alexithymia trait.
To investigate the relationship between alexithymia categories, trait anxiety and coping strategies, we carried out multivariate analyses of variance (Table 2 ). Significant differences were found for COPE and for trait anxiety (F = 3.95, P = 0.0001, g 2 = 0.25). Post hoc analysis showed that the significant differences found between alexithymia levels 1 and 2 and 1 and 3 for COPE lay in the use of 'AS' vs. PA, SS, TR, and PS. Post hoc power analysis revealed a power of 0.9 to detect differences at a 95% confidence interval.
We next turned to analysis of the independent variables to investigate the effects of adrenaline prescription, anaphylaxis, age and gender on COPE, trait anxiety, and total score for alexithymia (Table 3) .
There were significant effects for age group (F = 2.2, P = 0.04, g 2 = 0.17), for gender (F = 2.8, P = 0.01, g 2 = 0.21) and adrenaline prescription (F = 2.2, P = 0.04, g 2 = 0.18). Although we found no main effects for anaphylaxis, we did find a significant interaction between anaphylaxis and alexithymia (F = 6.000, P = 0.048, g 2 = 0.07). This finding shows a relationship between reporting anaphylaxis and higher scores on alexithymia. Post hoc analysis showed that participants aged 19 years and younger had higher total scores on alexithymia (mean = 51.0, SD = 1.7 vs 47.0, SD = 2.6). Trait anxiety was lower in the younger group (mean = 40.0, SD = 1.5 vs mean = 44.0, SD = 2.2). There were no significant differences in alexithymia scores between males and females (mean = 49.00, SD = 2.3 vs mean = 48.5, SD = 2.3), but significant differences were found in trait anxiety with females obtaining higher scores (mean = 45.0, SD = 1.8 vs mean 40.0, SD = 2.0). Furthermore, females were more likely to report higher scores on SS (mean = 33.0, SD = 1.3 vs mean = 26.0, SD = 1.2). There was a significant difference in SS and AS between those who were prescribed adrenaline and those without (mean = 34.0, SD = 2.2 vs mean = 27.5, SD = 0.7). With regard to AS, those who did not have adrenaline prescription had higher mean scores (mean = 27.0, SD = 1.5 vs mean = 22.5, SD = 1.5).
We investigated differences according to alexithymia subscales and anaphylaxis, adrenaline prescription, age group and gender. Multivariate analysis showed significant differences (F = 31.02, P < 0.0001, partial g 2 = 0.5) for alexithymia levels for each alexithymia subscale. We found two significant differences on independent variables; those 19 years and below have significantly higher scores on EOT (mean = 21.5, SD = 0.6 vs mean = 18.9, SD = 0.6) and those who reported anaphylaxis obtained higher mean scores on DIF than those who had not (mean 17.7, SD = 0.8 vs mean = 15.3, SD = 1.1). Multiple linear regression analyses determined the variables with the most weight in predicting higher scores on alexithymia. Only significant predictors were included in the final model. Table 4 shows that 'avoidance' explained over 40% of the variance in alexithymia controlling for the other significant factors. Trait anxiety explained over 30% of the variance followed by age, anaphylaxis and level of social support. Therefore, those who use 'avoidance' as a coping strategy, are younger, have experienced anaphylaxis and have a lower level of social support will report higher scores on alexithymia.
Discussion
Alexithymia has been associated with an expanding range of somatic pathologies such as inflammatory bowel disease, myocardial infarction, chronic respiratory diseases, dermatologic conditions, chronic pain, neuromuscular disorders, diabetes and food allergy (13, (17) (18) (19) (33) (34) (35) (36) (37) (38) . It has been found to increase unhealthy behaviours and susceptibility to organic diseases notably immune-mediated disorders via physiological, behavioural, cognitive or social pathways from childhood leading to adverse outcomes in adulthood (21, 22, 39) .
Chronic diseases that are characterized by disregulation of inflammation, such as food allergy, are particularly susceptible to modulation by stress and emotion. Our findings support a possible role for alexithymia in influencing clinical outcomes through a relationship with avoidant coping and negative affect. We found that 15% of the participants fell in alexithymia category. If we consider also borderline alexithymia, we reach the 47% of the sample. Results are in line with our previous study (13) , which showed a significant difference in the frequency of non-alexithymic individuals comparing food-allergic patients with matched controls. Healthy participants reported a prevalence of 10% for alexithymia and 28% for borderline alexithymia. Alexithymia in foodallergic patients vs. patients affected from other allergic diseases should be explored in the future.
Significant differences found between alexithymia levels 1 and 2 and 1 and 3 in coping style were explained by the use of 'AS' over all other possible strategies including PA, SS, TR and PS. Furthermore, regression analyses showed that 'avoidance' had the highest contribution in explaining alexithymia, followed by trait anxiety, age, anaphylaxis and social support. Respondents who achieved higher levels of alexithymia use 'avoidance' as a coping strategy, over and above other coping strategies such as problem solving and positive thinking, are younger, will have experienced anaphylaxis and will have a lower social support.
Using 'avoidance' as a coping strategy is associated with psychological distress in food allergy and can mediate the link between illness perceptions and outcomes (24) . The tendency to use 'avoidance' is compounded by problems in identifying, describing and regulating emotions and by an 'externally oriented cognitive style' which describes a propensity to be guided by strict rules, regulations and social conformity, which provides a sense of comfort and security for the individual. Qualitative studies (12, 40) on food allergy experience found that when adverse reactions occur in spite of 'the rules' being followed (e.g. telling restaurant staff that you cannot eat a meal containing peanut and then receiving such a meal), a traumatic 'transition' in the developmental process can occur. This transition leads to difficulty for some in effectively regulating emotions and in differentiating between physical and emotional symptoms. Although we found no main effects for anaphylaxis, we did find a significant interaction between anaphylaxis and alexithymia, demonstrating a relationship between reporting anaphylaxis and higher alexithymia scores. With regard to subscales, we found that those 19 years and below has significantly higher scores on EOT and those who reported anaphylaxis obtained higher mean scores on DIF than those who had not. In food allergy, parents (and health professionals) may be more focused on a child's physiological safety, rather than on their psychological well-being. Difficulty in identifying feelings may result in an altered interpretation of their physical condition and symptoms. Accurate perception of symptoms is a crucial factor for correct self-management in food allergy. In asthma, the use of emotion-focused coping strategies seems to be related to a worse perception of physical status, and in particular, denial could promote a poor clinical course in asthma (41) . Denial has also been found to be prevalent among a subgroup of food-allergic children and teens, sometimes referred to as 'minimization' (40), giving rise to risk-taking behaviours, such as not carrying an auto-injector, not informing food venues, and not telling friends about food allergy. The decline in the rate of alexithymia from early to late adolescence is consistent with the gradually improving cognitive skills relating to the processing of emotions.
We did not find any differences between genders on the alexithymia subscales, suggesting that both males and females had similar difficulties in identifying and describing feelings and in a propensity to EOT. However, although younger respondents obtained higher total scores on alexithymia, and lower on trait anxiety, this relationship was modified by gender. Females showed higher scores on SS, a strategy that typically shows gender differences, with lower rates found in males. It is possible that the use of social support may be inappropriate in some cases. Qualitative research has shown that avoidance is linked to support from a very few friends who 'understand' with new friendships shunned (40) . In previous research, alexithymia has been associated with patterns of affect intensity (males) and frequency (females), highlighting an overall deficit in the processing of emotions that is gender specific (5) .
Research has recognized alexithymia as one of several possible risk factors that may alter the general susceptibility to stress via physiological, behavioural, cognitive or social pathways (21) (22) (23) 39) . For most children who become allergic, the polarization of their immune system into an atopic phenotype probably occurs during early childhood. The establishment of the Th1/Th2 balance during early childhood and the final tuning at the important middle childhood years (42) implies that children may be especially vulnerable to environmental and lifestyle stressors affecting this balance. Increasing evidence links alexithymia to impaired immune function (43) , with some research reporting a diminished immunemediated cellular response in alexithymic individuals with over-secretion of glucocorticoids (35) . Alexithymia may skew the Th-1/Th-2 balance towards Th-2 dominant immunity and lower cell-mediated (Th-1) immune response and may increase an individual's risk of stress-related disorders. The upregulation of Th-2 response with impaired Th-1 response could contribute to the pathophysiology observed in allergic disease (43, 44) .
An increased understanding of the interplay between alexithymia's role in influencing clinical outcomes through a relationship with avoidant coping and negative affect can contribute to prevention and intervention in food allergy. In research, the links between alexithymia, immune function and psychophysiological activity stress the importance of considering the patient as a whole. In other words, the awareness of the bidirectional ('top-down and bottom-up') interactions between mind/brain and body may be particularly effective in chronic diseases, such as food allergy. In clinical practice, the belief that a patient is defensive can lead to frustration on the part of the clinician because the patient is regarded as withholding information that would allow the caregiver to help him or her (17) . In contrast, the construct of alexithymia created an alternative way for the clinician to considering these patients: that he or she has an emotional difficulty or a limitation or that they may be confused, rather than actively avoidant or uncooperative. Alexithymic patients tend not to adopt nuances in describing and discriminating feelings. They are more likely to express themselves in terms of bodily symptoms, providing excessive details of their health condition, behaviours and daily events (17, 39, 41) , which can be interpreted as valid attempts to describe personal experience via symptoms or practical details. Understanding that a patient 'cannot', rather than 'will not', identify, distinguish and verbally express emotions, can improve patient-clinician communication and allow the clinician to select interventions that are appropriate and targeted specifically to that patient (17, 39, 41) .
Health-related quality of life and other patient outcome measures might be used as tools to focus communication on coping with food allergy or in difficulties in managing risk. Feedback to the patient about the specific role of affect regulation in causing certain behaviours may constitute an important step in helping patients to explore more adaptive strategies. Although little research has been conducted on interventions for alexithymia, cognitive behavioural strategies to help a patient's awareness of their emotions have been described (21) . Interventions that are externally focused, such as contingency management, or that are relatively structured may be better suited to alexithymic individuals. Coping skills training, techniques relaxation, activity rest cycling and communications skills might be particularly useful (21) . Previous research on different chronic diseases highlighted the need to develop and test alexithymia interventions and examine their effects on important disease-related variables (e.g. HRQL, symptoms) (17, 21, (33) (34) (35) (36) (37) . A controlled study found a significant decrease in TAS scores among cardiac patients in psychological treatment but not in controls. Furthermore alexithymia reduction predicted better cardiovascular disease outcomes 2 years later (45) . Further evidence-based research aimed at exploring the effects of interventions for alexithymia on outcomes in food allergy are needed.
Given that this study was cross-sectional, the long-term stability of these findings requires further inquiry. Future research should also explore the possible impact of age, culture and gender-related variables.
Our findings suggest that an increased awareness of the construct of alexithymia will add value to clinicians' interactions with patients in everyday practice. In research, the use of a global approach in food allergy, directed towards addressing functional links between mind/brain, may contribute to a greater understanding of the psychological and physical outcomes associated with the condition. Further longitudinal and prospective studies are required to elucidate the nature of these relationships and interactions between different levels (e.g. biological, psychological, environmental).
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